JAX Antibody Development Summit - Geoff Hale
Fill form to unlock content
Loading, please wait
Error - something went wrong!
Access the On-Demand Video
Thank you!
Dr. Geoff Hale, CEO, mAbsolve, presents Characterisation of Novel Antibodies Which are Completely Silenced with Respect to Fc Binding Function as part of The Jackson Laboratory's Antibody Drug Development Summit.